Mesothelioma Research Centers

Some of the top cancer centers in the U.S. have specialized mesothelioma research centers. These include Brigham and Women’s Hospital in Boston, Baylor College of Medicine in Houston and the University of Chicago Medicine Comprehensive Cancer Center.

Content Contributors


Written By

Edited By

This page features: 11 cited research articles

Mesothelioma has a reputation as an aggressive cancer with a poor prognosis. It is stubbornly resistant to existing cancer therapies, so the greatest hope for patients rests on medical research and innovation.

Because mesothelioma is rare, there are not as many resources dedicated to it as there are for other diseases such as lung cancer or breast cancer.

There are a few American institutions that focus on improving treatment for mesothelioma. Many of them explore experimental treatment strategies by conducting clinical trials.

Brigham and Women’s: International Mesothelioma Program

The International Mesothelioma Program is one of the world’s top treatment centers for pleural mesothelioma. It is located in Boston at the prestigious Brigham and Women’s Hospital.

The program was founded in 2002 by Dr. David Sugarbaker, a pioneer in multimodal therapy for pleural mesothelioma. Many doctors consider the approach Sugarbaker developed in Boston as the gold standard for patients eligible for surgery.

Now under the leadership of Dr. Raphael Bueno, the International Mesothelioma Program continues to research ways to improve treatment for pleural mesothelioma.

Baylor College of Medicine: Mesothelioma Treatment Center

In 2014, Sugarbaker became the first director of the new Lung Institute at the Baylor College of Medicine in Houston. He arrived with the resolution to build another world-class mesothelioma program, as he had in Boston.

As a result, Baylor’s Mesothelioma Treatment Center quickly became a powerhouse for medical science. There, researchers can draw on resources of one of the largest health science complexes in the world.

Sugarbaker’s team looks for ways to improve intraoperative chemotherapy for pleural mesothelioma. They also test combinations of immunotherapy drugs in clinical trials.

Interested in Participating in a Mesothelioma Clinical Trial?

Our Patient Advocates can help you find clinical trials currently enrolling new patients with mesothelioma.

Get Free Help Now

University of Chicago Cancer Center: Mesothelioma Program

In 2002, researchers at the University of Chicago Medicine Comprehensive Cancer Center rewrote the book on malignant mesothelioma. It was here that a team led by Dr. Nicholas Vogelzang discovered the first chemotherapy combination to be FDA-approved for mesothelioma treatment.

When immunotherapy began to revolutionize lung cancer treatment, Chicago’s mesothelioma program saw its potential. In 2015, the program conducted one of the first major trials of pembrolizumab (Keytruda) for mesothelioma.

The mesothelioma program’s research efforts continue under the leadership of Dr. Hedy Kindler, a former president of the International Mesothelioma Interest Group.

H. Lee Moffitt: Mesothelioma Research and Treatment Center

In 2012, the H. Lee Moffitt Cancer Center & Research Institute in Tampa set up a specialized mesothelioma program to take full advantage of its doctors’ talent and experience.

Moffitt’s research team focuses on perfecting intensity-modulated radiation therapy and testing experimental immunotherapy treatments. They have also pioneered a method of injecting chemotherapy only into blood vessels that lead directly to a patient’s tumor.

The Mesothelioma Research and Treatment Center conducts numerous clinical trials, including some open to patients with hard-to-treat cell types who are usually ineligible. The program is led by Dr. Scott Antonia.

Pacific Heart, Lung & Blood Institute: Pacific Mesothelioma Center

The Pacific Heart, Lung & Blood Institute is a nonprofit cancer research organization founded in 2002. The Los Angeles-based institute established its mesothelioma division in 2012 to expand its mission to develop immunotherapy and gene therapy treatments for cancer.

The Pacific Mesothelioma Center’s research is guided by the director of UCLA’s mesothelioma program, Dr. Robert Cameron. The center follows Cameron’s philosophy of combining lung-sparing surgery with traditional and experimental cancer therapies.

The center has experimented with using stem cells as a drug-delivery vehicle for mesothelioma treatment. It also hosts its own tissue bank for research purposes.

University of Vermont: Shukla Research Lab

The Department of Pathology at the University of Vermont Larner College of Medicine has a laboratory devoted to studying asbestos-related cancer.

The lab is run by Dr. Arti Shukla, an associate professor of pathology and laboratory medicine. Her team’s goal is to discover the molecular basis for how asbestos causes disease.

Their work made headlines in 2018 when they published a report on how asbestos-exposed lung cells send signals that change the gene expression of mesothelial cells.

Massachusetts General: Vaccine and Immunotherapy Center

Massachusetts General Hospital in Boston founded the Vaccine and Immunotherapy Center in 2009. Its mission is to rapidly turn laboratory discoveries into improved medical treatments.

The center’s work is guided by Dr. Mark Poznansky, a professor at Harvard Medical School. One of the center’s laboratories, headed by Dr. Huabiao Chen, focuses on testing immunotherapy combinations that show promise for mesothelioma treatment.

Get the Best Treatment Options

Find a Doctor Mesothelioma Packet

Order Your Free Treatment Guide

Get Yours Now

Find a Mesothelioma Clinical Trial Near You

Get Help Now

Share this article

Last Modified September 24, 2018

Registered Nurse and Patient Advocate

Karen Selby joined in 2009. She is a registered nurse with a background in oncology and thoracic surgery and was the regional director of a tissue bank before becoming a Patient Advocate at The Mesothelioma Center. Karen has assisted surgeons with thoracic surgeries such as lung resections, lung transplants, pneumonectomies, pleurectomies and wedge resections. She is also a member of the Academy of Oncology Nurse & Patient Navigators.

Walter Pacheco, Managing Editor at
Edited by
Reviewed by placeholder
Medical Review By

7 Cited Article Sources

  1. Baylor College of Medicine. (n.d.). Welcome to the Mesothelioma Treatment Center.
    Retrieved from:
  2. Brigham and Women’s Hospital. (n.d.). International Mesothelioma Program.
    Retrieved from:
  3. Massachusetts General Hospital. (n.d.). Vaccine & Immunotherapy Center.
    Retrieved from:
  4. Moffitt Cancer Center. (n.d.). Mesothelioma Treatment Information.
    Retrieved from:
  5. Pacific Heart, Lung and Blood Institute. (n.d.). Pacific Mesothelioma Center.
    Retrieved from:
  6. University of Chicago. (n.d.). Mesothelioma.
    Retrieved from:
  7. University of Vermont. (n.d.). Shukla Research Lab. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

On This Page

Back to Top

On This Page

Content Contributors

Share Our Page

Free Awareness Wristbands

Get free mesothelioma wristbands to show support for a loved one

Get your wristbands Mesothelioma Wristbands
Chat live with a patient advocate now loading spinner